Current Infectious Disease Reports

, Volume 15, Issue 3, pp 269–277

Reducing Central Line Infections in Pediatric and Neonatal Patients

  • Simon Li
  • Edward Vincent S. Faustino
  • Sergio G. Golombek
Pediatric Infectious Diseases (I Brook, Section Editor)


The stakes for the prevention of central line associated bloodstream infections (CLABSIs) have increased dramatically over the past decade. Over the past 10 years, the rate of CLABSI in the pediatric population has dropped markedly due to the significant investment in this initiative. Although there has been a substantial increase in studies on CLABSIs, difficulties in studying CLABSIs have limited the quality of the evidence produced. These difficulties include challenges in the sample size required to complete trials, pressure from external regulatory forces to reduce CLABSI rates, and challenges in defining CLABSIs. The definition of CLABSI is continuously being updated to improve the misclassification bias inherent in defining CLABSI. This is especially relevant given the stress placed on decreasing health-care-associated infections and the negative consequences associated if unsuccessful. In order to prevent CLABSIs, pediatric and neonatal intensive care units have formed bundles of basic evidenced-based strategies leading to effective reduction of CLABSIs. These basic bundles have been modified for spread to other nonintensive care areas, also yielding great results. However, additional therapies above the basic bundle have yielded mixed results, and more research is needed to understand the cost effectiveness of these therapies in the setting of decreasing CLABSI rates. As a goal, a “getting to zero” CLABSI rate should be set, but it may not be possible without significant resource allocation.


Catheter-related infections Central venous catheterization Health-care-associated infections Intensive care unit Neonatal Pediatrics 


Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.
    Kohn LT, Corrigan JM, Donaldson MS. National Research Council. To err is human: Building a safer health system. Washington, DC: The National Academies Press; 2000.Google Scholar
  2. 2.
    Centers for Disease Control and Prevention (CDC). Vital signs: central line-associated blood stream infections—United States, 2001, 2008, and 2009. MMWR Morb Mortal Wkly Rep. 2011;60(8):243–8.Google Scholar
  3. 3.
    • 111th Congress Public Law 148. An act entitled The Patient Protection and Affordable Care Act. 2010. Accessed 23 Jan 2013. This document is the actual law that was enacted with the purpose of decreasing the number of uninsured and reducing health-care cost, along with improving health-care outcomes and delivery.
  4. 4.
    •• Miller MR, Niedner MF, Huskins WC, Colantuoni E, Yenokyan G, Moss M, et al. National Association of Children's Hospitals and Related Institutions Pediatric Intensive Care Unit Central Line-Associated Bloodstream Infection Quality Transformation Teams. Reducing PICU central line-associated bloodstream infections: 3-year results. Pediatrics. 2011;128(5):e1077–83. This is the follow-up study showing the success of a multicenter effort to eradicate CLABSIs in the PICU. It also describes their finding regarding CHGIS used at some of their centers.PubMedCrossRefGoogle Scholar
  5. 5.
    National Nosocomial Infections Surveillance System. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control. 2004;32(8):470–85.CrossRefGoogle Scholar
  6. 6.
    •• Dudeck MA, Horan TC, Peterson KD, Allen-Bridson K, Morrell G, Pollock DA, Edwards. JR. National Healthcare Safety Network (NHSN) Report, Data Summary for 2010, Device-associated Module. Accessed 23 Jan 2013. The most recent publication of HAIs data from NHSN.
  7. 7.
    Schulman J, Stricof R, Stevens TP, Horgan M, Gase K, Holzman IR, et al. New York State Regional Perinatal Care Centers. Statewide NICU central-line-associated bloodstream infection rates decline after bundles and checklists. Pediatrics. 2011;127(3):436–44.PubMedCrossRefGoogle Scholar
  8. 8.
    Li S, Bizzarro MJ. Prevention of central line associated bloodstream infections in critical care units. Curr Opin Pediatr. 2011;23(1):85–90.PubMedCrossRefGoogle Scholar
  9. 9.
    Niedner MF, Huskins WC, Colantuoni E, Muschelli J, Harris 2nd JM, Rice TB, et al. Epidemiology of central line-associated bloodstream infections in the pediatric intensive care unit. Infect Control Hosp Epidemiol. 2011;32(12):1200–8.PubMedCrossRefGoogle Scholar
  10. 10.
    PubMed [Internet]. Bethesda (MD): National Library of Medicine (US). Available from: Accessed 23 Jan 2013.
  11. 11.
    • Timsit JF, Schwebel C, Bouadma L, Geffroy A, Garrouste-Orgeas M, Pease S, et al. Chlorhexidine-impregnated sponges and less frequent dressing changes for prevention of catheter-related infections in critically ill adults: a randomized controlled trial. JAMA. 2009;301(12):1231–41. This study represents the largest multicenter adult trial of CHGIS dressing. It is especially relevant because it was performed after the application of basic bundle strategy and the sites had low baseline rates.PubMedCrossRefGoogle Scholar
  12. 12.
    Wheeler DS, Giaccone MJ, Hutchinson N, Haygood M, Bondurant P, Demmel K, et al. A hospital-wide quality-improvement collaborative to reduce catheter-associated bloodstream infections. Pediatrics. 2011;128(4):e995–e1004. quiz e1004-7.PubMedCrossRefGoogle Scholar
  13. 13.
    • Rosenthal VD, Ramachandran B, Villamil-Gómez W, Armas-Ruiz A, Navoa-Ng JA, Matta-Cortés L, et al. Impact of a multidimensional infection control strategy on central line-associated bloodstream infection rates in pediatric intensive care units of five developing countries: findings of the International Nosocomial Infection Control Consortium (INICC). Infection. 2012;40(4):415–23. The first published study of this multicenter international collaborative effort to reduce CLABSIs in the PICU.PubMedCrossRefGoogle Scholar
  14. 14.
    •• National Healthcare Safety Network, CDC. NHSN Patient Safety Component Manual: 4.Central Line-Associated Bloodstream Infection (CLABSI) Event Guidelines and procedures for monitoring CLABSI. January 2013. Available from Accessed 23 Jan 2013. This is the most recent and widely adopted definition for CLABSI from the CDC.
  15. 15.
    • Niedner MF. National Association of Children's Hospitals and Related Institutions Pediatric Intensive Care Unit Patient Care FOCUS Group. The harder you look, the more you find: Catheter-associated bloodstream infection surveillance variability. Am J Infect Control. 2010;38(8):585–95. This is the first study to look at the variability among different sites that is present when collecting surveillance data for the NHSN even in the light of a formalized definition for CLABSI.PubMedCrossRefGoogle Scholar
  16. 16.
    Edwards JR, Peterson KD, Mu Y, Banerjee S, Allen-Bridson K, Morrell G, et al. National Healthcare Safety Network (NHSN) report: data summary for 2006 through 2008, issued December 2009. Am J Infect Control. 2009;37(10):783–805.PubMedCrossRefGoogle Scholar
  17. 17.
    •• Miller MR, Griswold M, Harris 2nd JM, et al. Decreasing PICU catheter associated bloodstream infections: NACHRI’s quality transformation efforts. Pediatrics. 2010;125:206–13. The first published study of this multicenter national collaborative effort to reduce CLABSIs in the PICU.PubMedCrossRefGoogle Scholar
  18. 18.
    Bizzarro MJ, Sabo B, Noonan M, et al. A quality improvement initiative to reduce central line associated bloodstream infections in a neonatal intensive care unit. Infect Control Hosp Epidemiol. 2010;31:241–8.PubMedCrossRefGoogle Scholar
  19. 19.
    Golombek SG, Rohan AJ, Parvez B, Salice AL, LaGamma EF. "Proactive" management of percutaneously inserted central catheters results in decreased incidence of infection in the ELBW population. J Perinatol. 2002;22(3):209–13.PubMedCrossRefGoogle Scholar
  20. 20.
    • Rosenthal VD, Maki DG, Graves N. The International Nosocomial Infection Control Consortium (INICC): goals and objectives, description of surveillance methods, and operational activities. Am J Infect Control. 2008;36(9):e1–e12. This article describes the multicenter international collaborative effort to reduce HAIs.PubMedCrossRefGoogle Scholar
  21. 21.
    • Rosenthal VD, Lynch P, Jarvis WR, Khader IA, Richtmann R, Jaballah NB, et al. Apisarnthanarak A; International Nosocomial Infection Control Consortium members. Socioeconomic impact on device-associated infections in limited-resource neonatal intensive care units: findings of the INICC. Infection. 2011;39(5):439–50. The first published study of this multicenter international collaborative effort to reduce CLABSIs in the NICU.PubMedCrossRefGoogle Scholar
  22. 22.
    •• National Association of Children's Hospitals and Related Institutions (NACRHI). Hematology/Oncology Central Line Associated Blood Stream Infections Collaborative. November 2012. Accessed 20 January 2013. This document is the most updated information from the NACHRI hematology/oncology collaborative effort to reduce CLABSIs.
  23. 23.
    Barrell C, Covington L, Bhatia M, Robison J, Patel S, Jacobson JS, et al. Preventive strategies for central line-associated bloodstream infections in pediatric hematopoietic stem cell transplant recipients. Am J Infect Control. 2012;40(5):434–9.PubMedCrossRefGoogle Scholar
  24. 24.
    • Schwebel C, Lucet JC, Vesin A, Arrault X, Calvino-Gunther S, Bouadma L, et al. Economic evaluation of chlorhexidine-impregnated sponges for preventing catheter-related infections in critically ill adults in the Dressing Study. Crit Care Med. 2012;40(1):11–7. The publication is the a priori planned economic analysis of CHGIS from the largest adult multicenter CHGIS trial.PubMedCrossRefGoogle Scholar
  25. 25.
    Mayer S, Boos M, Beyer A, Fluit AC, Schmitz FJ. Distribution of the antiseptic resistance genes qacA, qacB and qacC in 497 methicillin-resistant and-susceptible European isolates of Staphylococcus aureus. J Antimicrob Chemother. 2001;47(6):896–7.PubMedCrossRefGoogle Scholar
  26. 26.
    Longtin J, Seah C, Siebert K, McGeer A, Simor A, Longtin Y, et al. Distribution of antiseptic resistance genes qacA, qacB, and smr in methicillin-resistant Staphylococcus aureus isolated in Toronto, Canada, from 2005 to 2009. Antimicrob Agents Chemother. 2011;55(6):2999–3001.PubMedCrossRefGoogle Scholar
  27. 27.
    Zhang M, O'Donoghue MM, Ito T, Hiramatsu K, Boost MV. Prevalence of antiseptic-resistance genes in Staphylococcus aureus and coagulase-negative staphylococci colonising nurses and the general population in Hong Kong. J Hosp Infect. 2011;78(2):113–7.PubMedCrossRefGoogle Scholar
  28. 28.
    Shamsudin MN, Alreshidi MA, Hamat RA, Alshrari AS, Atshan SS, Neela V. High prevalence of qacA/B carriage among clinical isolates of meticillin-resistant Staphylococcus aureus in Malaysia. J Hosp Infect. 2012;81(3):206–8.PubMedCrossRefGoogle Scholar
  29. 29.
    Johnson DC, Johnson FL, Goldman S. Preliminary results treating persistent central venous catheter infections with the antibiotic lock technique in pediatric patients. Pediatr Infect Dis J. 1994;13(10):930–1.PubMedCrossRefGoogle Scholar
  30. 30.
    Dannenberg C, Bierbach U, Rothe A, Beer J, Körholz D. Ethanol-lock technique in the treatment of bloodstream infections in pediatric oncology patients with broviac catheter. J Pediatr Hematol Oncol. 2003;25(8):616–21.PubMedCrossRefGoogle Scholar
  31. 31.
    Henrickson KJ, Axtell RA, Hoover SM, Kuhn SM, Pritchett J, Kehl SC, et al. Prevention of central venous catheter-related infections and thrombotic events in immunocompromised children by the use of vancomycin/ciprofloxacin/heparin flush solution: a randomized, multicenter, double-blind trial. J Clin Oncol. 2000;18(6):1269–78.PubMedGoogle Scholar
  32. 32.
    Oliveira C, Nasr A, Brindle M, Wales PW. Ethanol locks to prevent catheter-related bloodstream infections in parenteral nutrition: a meta-analysis. Pediatrics. 2012;129(2):318–29.PubMedCrossRefGoogle Scholar
  33. 33.
    Wolf J, Shenep JL, Clifford V, Curtis N, Flynn PM. Ethanol lock therapy in pediatric hematology and oncology. Pediatr Blood Cancer. 2013;60(1):18–25.PubMedCrossRefGoogle Scholar
  34. 34.
    Lundgren IS, Zhou C, Malone FR, McAfee NG, Gantt S, Zerr DM. Central venous catheter repair is associated with an increased risk of bacteremia and central line-associated bloodstream infection in pediatric patients. Pediatr Infect Dis J. 2012;31(4):337–40.PubMedCrossRefGoogle Scholar
  35. 35.
    • Lin MY, Hota B, Khan YM, Woeltje KF, Borlawsky TB, Doherty JA, et al. CDC Prevention Epicenter Program. Quality of traditional surveillance for public reporting of nosocomial bloodstream infection rates. JAMA. 2010;304(18):2035–41. This study assessed the variability among different sites that is present when collecting surveillance data for the NHSN, as compared with a computer algorithm.PubMedCrossRefGoogle Scholar
  36. 36.
    Choi SW, Chang L, Hanauer DA, Shaffer-Hartman J, Teitelbaum D, Lewis I, et al. Rapid reduction of central line infections in hospitalized pediatric oncology patients through simple quality improvement methods. Pediatr Blood Cancer. 2013;60(2):262–9.PubMedCrossRefGoogle Scholar
  37. 37.
    McLaws ML, Burrell AR. Zero risk for central line-associated bloodstream infection: are we there yet? Crit Care Med. 2012;40(2):388–93.PubMedCrossRefGoogle Scholar
  38. 38.
    •• O'Grady NP, Alexander M, Burns LA, Dellinger EP, Garland J, Heard SO, et al. Healthcare Infection Control Practices Advisory Committee (HICPAC). Guidelines for the prevention of intravascular catheter-related infections. Clin Infect Dis. 2011;52(9):e162–93. The most recent evidence-based recommendations from the federal United States advisory committee on the best practices for preventing CLABSIs.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  • Simon Li
    • 1
  • Edward Vincent S. Faustino
    • 2
  • Sergio G. Golombek
    • 3
  1. 1.Division of Pediatric Critical Care Medicine, New York Medical CollegeMaria Fareri Children’s HospitalValhallaUSA
  2. 2.Department of PediatricsYale University School of MedicineNew HavenUSA
  3. 3.New York Medical College, Division of Newborn Medicine, Maria Fareri Children’s HospitalWestchester Medical CenterValhallaUSA

Personalised recommendations